| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 7.22e-10 | 4 | 105 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 7.22e-10 | 4 | 105 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.59e-09 | 5 | 105 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.50e-08 | 7 | 105 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 8.91e-08 | 9 | 105 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.48e-07 | 10 | 105 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC18B1 SLC35D1 CLCN3 SLC22A8 CLCN6 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 SLC16A10 | 4.57e-07 | 296 | 105 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.98e-07 | 13 | 105 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | transporter activity | SLC39A11 FLVCR2 PKD1L2 SLC18B1 NDUFS1 SLC35D1 CLCN3 KCNA7 SLC22A8 CLCN6 NALCN KCNG4 SLC5A6 GHITM OSBPL10 SLC39A6 SV2C SLC13A5 SLC47A1 ABCD2 TMEM184B SLC16A10 | 7.61e-07 | 1289 | 105 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC18B1 NDUFS1 SLC35D1 CLCN3 SLC22A8 CLCN6 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 1.33e-06 | 477 | 105 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC39A11 FLVCR2 PKD1L2 SLC18B1 NDUFS1 SLC35D1 CLCN3 KCNA7 SLC22A8 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SV2C SLC13A5 SLC47A1 ABCD2 SLC16A10 | 2.95e-06 | 1180 | 105 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | antiporter activity | 8.37e-06 | 138 | 105 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC39A11 PKD1L2 SLC18B1 NDUFS1 CLCN3 KCNA7 SLC22A8 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 9.90e-06 | 758 | 105 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC39A11 PKD1L2 SLC18B1 NDUFS1 CLCN3 KCNA7 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 6.96e-05 | 793 | 105 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC39A11 PKD1L2 SLC18B1 NDUFS1 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 1.13e-04 | 627 | 105 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC35D1 SLC22A8 SLC5A6 SLC39A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 1.59e-04 | 293 | 105 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC39A11 PKD1L2 SLC18B1 NDUFS1 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 1.92e-04 | 664 | 105 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.00e-04 | 55 | 105 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.06e-04 | 190 | 105 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 6.26e-04 | 74 | 105 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC39A11 PKD1L2 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 | 7.77e-04 | 465 | 105 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 7.93e-04 | 207 | 105 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 8.97e-04 | 212 | 105 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.07e-03 | 301 | 105 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 1.46e-03 | 11 | 105 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.46e-03 | 11 | 105 | 2 | GO:0005247 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 3.28e-09 | 5 | 106 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | signal peptide processing | 6.34e-07 | 14 | 106 | 4 | GO:0006465 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.49e-06 | 17 | 106 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.49e-06 | 17 | 106 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.49e-06 | 17 | 106 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.91e-06 | 18 | 106 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.21e-06 | 47 | 106 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.41e-06 | 23 | 106 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 6.99e-06 | 52 | 106 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | sulfation | 1.06e-05 | 27 | 106 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.80e-05 | 106 | 106 | 6 | GO:0034308 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.63e-05 | 13 | 106 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.71e-05 | 73 | 106 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC39A11 SRI ACTN4 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 6.13e-05 | 1017 | 106 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | peptide metabolic process | 7.29e-05 | 84 | 106 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC39A11 SRI ACTN4 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 7.34e-05 | 922 | 106 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 9.29e-05 | 142 | 106 | 6 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 9.29e-05 | 142 | 106 | 6 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 9.29e-05 | 142 | 106 | 6 | GO:0034032 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC39A11 SRI ACTN4 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 9.32e-05 | 942 | 106 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC39A11 SRI ACTN4 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 1.78e-04 | 1115 | 106 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 1.79e-04 | 160 | 106 | 6 | GO:0051384 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.97e-04 | 163 | 106 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC39A11 SRI ACTN4 FLVCR2 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 SLC22A8 CLCN6 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 2.11e-04 | 1374 | 106 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.25e-04 | 167 | 106 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | INPP5B ENPP3 NDUFS1 ACOT12 ABHD4 SULT1A2 GK SULT1A4 SULT1A1 SULT1A3 LIPG ENTPD5 OSBPL10 ELOVL3 SERAC1 PINK1 | 2.34e-04 | 1142 | 106 | 16 | GO:0019637 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | EPRS1 CPT1A SLC35D1 SLC22A8 SLC5A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 2.66e-04 | 410 | 106 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC39A11 SRI ACTN4 FLVCR2 PKD1L2 SLC18B1 CBLIF CLCN3 KCNA7 NALCN KCNG4 SLC5A6 GHITM SLC39A6 SLC13A5 SLC47A1 | 2.71e-04 | 1157 | 106 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | alcohol metabolic process | ACER3 INPP5B ABHD4 SULT1A2 GK SULT1A4 SULT1A1 SULT1A3 AKR1B15 | 2.76e-04 | 412 | 106 | 9 | GO:0006066 |
| GeneOntologyBiologicalProcess | organic acid transport | EPRS1 CPT1A SLC35D1 SLC22A8 SLC5A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 2.76e-04 | 412 | 106 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | organic anion transport | EPRS1 CPT1A SLC35D1 SLC22A8 SLC5A6 SLC39A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 3.22e-04 | 515 | 106 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | response to corticosteroid | 3.90e-04 | 185 | 106 | 6 | GO:0031960 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 4.04e-04 | 121 | 106 | 5 | GO:0006576 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | ENPP3 NDUFS1 ACOT12 SULT1A2 SULT1A4 SULT1A1 SULT1A3 ENTPD5 ELOVL3 PINK1 | 4.22e-04 | 533 | 106 | 10 | GO:0009259 |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | LDHAL6A ACER3 INPP5B ABHD4 SULT1A2 GK SULT1A4 SULT1A1 SULT1A3 AKR1B15 SLC16A10 | 4.60e-04 | 641 | 106 | 11 | GO:1901615 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | ENPP3 NDUFS1 ACOT12 SULT1A2 SULT1A4 SULT1A1 SULT1A3 ENTPD5 ELOVL3 PINK1 | 4.68e-04 | 540 | 106 | 10 | GO:0019693 |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 5.75e-04 | 74 | 106 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 5.75e-04 | 74 | 106 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | ACOT12 SLC35D1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 SLC5A6 ELOVL3 | 5.95e-04 | 365 | 106 | 8 | GO:0006790 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | SRI CPT1A FZD4 ADORA3 SULT1A2 SULT1A4 SULT1A1 SULT1A3 AKR1B15 SMAD2 SLC16A10 | 7.87e-04 | 684 | 106 | 11 | GO:0010817 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 8.18e-04 | 213 | 106 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 8.36e-04 | 142 | 106 | 5 | GO:0018958 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 1.01e-03 | 148 | 106 | 5 | GO:0009308 | |
| GeneOntologyCellularComponent | signal peptidase complex | 2.51e-06 | 6 | 106 | 3 | GO:0005787 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 1.36e-04 | 20 | 106 | 3 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 1.82e-04 | 22 | 106 | 3 | GO:1905286 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 6.99e-04 | 8 | 106 | 2 | GO:0071144 | |
| MousePheno | enlarged gallbladder | 2.02e-05 | 28 | 82 | 4 | MP:0009342 | |
| MousePheno | encephalopathy | 3.40e-05 | 2 | 82 | 2 | MP:0013806 | |
| MousePheno | abnormal gallbladder size | 3.49e-05 | 32 | 82 | 4 | MP:0020134 | |
| MousePheno | abnormal skeletal muscle morphology | ALS2 ACTN4 FZD4 LRIG3 SULT1A2 SULT1A4 SULT1A1 SULT1A3 GHITM PARL SERAC1 TMEM184B | 3.81e-05 | 508 | 82 | 12 | MP:0000759 |
| Domain | Peptidase_S26B | 2.95e-05 | 2 | 102 | 2 | IPR001733 | |
| Domain | Pept_S26A_signal_pept_1_Ser-AS | 2.95e-05 | 2 | 102 | 2 | IPR019756 | |
| Domain | Sulfotransferase_dom | 4.32e-05 | 36 | 102 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 4.32e-05 | 36 | 102 | 4 | PF00685 | |
| Domain | MFS_1 | 6.37e-05 | 77 | 102 | 5 | PF07690 | |
| Domain | MFS | 6.37e-05 | 77 | 102 | 5 | IPR011701 | |
| Domain | Pept_S26A_signal_pept_1_CS | 8.83e-05 | 3 | 102 | 2 | IPR019758 | |
| Domain | SPASE_I_3 | 1.76e-04 | 4 | 102 | 2 | PS00761 | |
| Domain | Peptidase_S24 | 1.76e-04 | 4 | 102 | 2 | PF00717 | |
| Domain | - | 1.76e-04 | 4 | 102 | 2 | 2.10.109.10 | |
| Domain | Peptidase_S24_S26A/B/C | 1.76e-04 | 4 | 102 | 2 | IPR015927 | |
| Domain | SPASE_I_1 | 1.76e-04 | 4 | 102 | 2 | PS00501 | |
| Domain | Peptidase_S24/S26_b-rbn | 1.76e-04 | 4 | 102 | 2 | IPR028360 | |
| Domain | Peptidase_S24_S26 | 1.76e-04 | 4 | 102 | 2 | IPR019759 | |
| Domain | MFS | 3.14e-04 | 108 | 102 | 5 | PS50850 | |
| Domain | EF-hand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 4.37e-04 | 6 | 102 | 2 | PF08726 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 5.52e-04 | 69 | 102 | 4 | IPR020636 | |
| Domain | Dwarfin | 8.09e-04 | 8 | 102 | 2 | IPR013790 | |
| Domain | DWB | 8.09e-04 | 8 | 102 | 2 | SM00524 | |
| Domain | MH2 | 8.09e-04 | 8 | 102 | 2 | PS51076 | |
| Domain | MH1 | 8.09e-04 | 8 | 102 | 2 | PS51075 | |
| Domain | - | 8.09e-04 | 8 | 102 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 8.09e-04 | 8 | 102 | 2 | IPR013019 | |
| Domain | MH2 | 8.09e-04 | 8 | 102 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 8.09e-04 | 8 | 102 | 2 | IPR001132 | |
| Domain | MFS_dom | 8.42e-04 | 134 | 102 | 5 | IPR020846 | |
| Domain | Cl-channel_core | 1.04e-03 | 9 | 102 | 2 | IPR014743 | |
| Domain | - | 1.04e-03 | 9 | 102 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.04e-03 | 9 | 102 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.04e-03 | 9 | 102 | 2 | IPR001807 | |
| Domain | MAD_homology1_Dwarfin-type | 1.88e-03 | 12 | 102 | 2 | IPR003619 | |
| Domain | DWA | 1.88e-03 | 12 | 102 | 2 | SM00523 | |
| Domain | MH1 | 1.88e-03 | 12 | 102 | 2 | PF03165 | |
| Domain | Zip | 2.57e-03 | 14 | 102 | 2 | PF02535 | |
| Domain | ZIP | 2.57e-03 | 14 | 102 | 2 | IPR003689 | |
| Domain | CBS | 3.37e-03 | 16 | 102 | 2 | SM00116 | |
| Domain | SMAD_dom-like | 3.37e-03 | 16 | 102 | 2 | IPR017855 | |
| Domain | - | 3.37e-03 | 16 | 102 | 2 | 2.60.200.10 | |
| Domain | Channel_four-helix_dom | 3.74e-03 | 57 | 102 | 3 | IPR027359 | |
| Domain | - | 3.74e-03 | 57 | 102 | 3 | 1.20.120.350 | |
| Domain | LH2 | 4.27e-03 | 18 | 102 | 2 | SM00308 | |
| Domain | CBS_dom | 5.26e-03 | 20 | 102 | 2 | IPR000644 | |
| Domain | CBS | 5.26e-03 | 20 | 102 | 2 | PF00571 | |
| Domain | CBS | 5.26e-03 | 20 | 102 | 2 | PS51371 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 5.56e-09 | 5 | 83 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 7.67e-07 | 13 | 83 | 4 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.54e-06 | 22 | 83 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 9.08e-06 | 23 | 83 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 1.09e-05 | 24 | 83 | 4 | M16289 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SRI SLC35D1 CLCN3 PSME4 SLC22A8 CLCN6 NALCN LIPG SLC5A6 PARL SLC39A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 2.23e-05 | 736 | 83 | 15 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SRI SLC35D1 PSME4 SLC22A8 CLCN6 NALCN LIPG SLC5A6 PARL SLC39A6 SLC13A5 SLC47A1 ABCD2 SLC16A10 | 3.95e-05 | 681 | 83 | 14 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 7.78e-05 | 238 | 83 | 8 | MM15076 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.85e-05 | 39 | 83 | 4 | MM15695 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.07e-04 | 249 | 83 | 8 | M5988 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.26e-04 | 17 | 83 | 3 | M39483 | |
| Pathway | WP_RETINOL_METABOLISM | 1.27e-04 | 44 | 83 | 4 | MM15851 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.16e-04 | 107 | 83 | 5 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.53e-04 | 109 | 83 | 5 | M18788 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 5.06e-04 | 6 | 83 | 2 | M39437 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.44e-04 | 29 | 83 | 3 | M45015 | |
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 24318996 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 8424956 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 33414449 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 8943792 | ||
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 8.47e-11 | 4 | 107 | 4 | 12390022 | |
| Pubmed | 8.47e-11 | 4 | 107 | 4 | 25370010 | ||
| Pubmed | 4.22e-10 | 5 | 107 | 4 | 11389699 | ||
| Pubmed | 4.22e-10 | 5 | 107 | 4 | 29908303 | ||
| Pubmed | 4.22e-10 | 5 | 107 | 4 | 24802129 | ||
| Pubmed | 4.22e-10 | 5 | 107 | 4 | 25053625 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 12438748 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.87e-09 | 8 | 107 | 4 | 10594240 | |
| Pubmed | 1.05e-08 | 9 | 107 | 4 | 9166597 | ||
| Pubmed | 1.05e-08 | 9 | 107 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 1.05e-08 | 9 | 107 | 4 | 23207770 | |
| Pubmed | 1.05e-08 | 9 | 107 | 4 | 8468045 | ||
| Pubmed | 1.05e-08 | 9 | 107 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.05e-08 | 9 | 107 | 4 | 9060415 | |
| Pubmed | 1.05e-08 | 9 | 107 | 4 | 9177785 | ||
| Pubmed | 1.75e-08 | 10 | 107 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.75e-08 | 11 | 107 | 4 | 7613026 | |
| Pubmed | 2.75e-08 | 11 | 107 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.75e-08 | 11 | 107 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.75e-08 | 11 | 107 | 4 | 9034160 | |
| Pubmed | 2.75e-08 | 11 | 107 | 4 | 10720750 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 2.83e-08 | 3 | 107 | 3 | 8363592 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 9855620 | ||
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 8912648 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 4.11e-08 | 12 | 107 | 4 | 7706460 | |
| Pubmed | 5.93e-08 | 13 | 107 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.93e-08 | 13 | 107 | 4 | 17425406 | |
| Pubmed | 1.13e-07 | 15 | 107 | 4 | 1741163 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 32152050 | ||
| Pubmed | 2.51e-07 | 18 | 107 | 4 | 20056724 | ||
| Pubmed | 4.87e-07 | 21 | 107 | 4 | 32301970 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 3.34e-06 | 10 | 107 | 3 | 11535246 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12833571 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 3100621 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 9.38e-06 | 2 | 107 | 2 | 14871892 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 34010028 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 9.38e-06 | 2 | 107 | 2 | 23358261 | |
| Pubmed | Structural and affinity studies of IgM polyreactive natural autoantibodies. | 9.38e-06 | 2 | 107 | 2 | 8993018 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23557398 | ||
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 9.38e-06 | 2 | 107 | 2 | 38069221 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11207031 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 9.38e-06 | 2 | 107 | 2 | 31400758 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12761191 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 2263605 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 9.38e-06 | 2 | 107 | 2 | 20936502 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15522311 | ||
| Pubmed | Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. | 9.38e-06 | 2 | 107 | 2 | 21355049 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10543947 | ||
| Pubmed | Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. | 9.38e-06 | 2 | 107 | 2 | 20037648 | |
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 9.38e-06 | 2 | 107 | 2 | 7581483 | |
| Pubmed | HAMLET binding to α-actinin facilitates tumor cell detachment. | 9.38e-06 | 2 | 107 | 2 | 21408150 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29705271 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28797528 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15752422 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 1936125 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23454549 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20417180 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15219549 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 37450367 | ||
| Pubmed | Amino acid sequence of the light chain variable region from a mouse anti-digoxin hybridoma antibody. | 9.38e-06 | 2 | 107 | 2 | 6404298 | |
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 9.38e-06 | 2 | 107 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 9.38e-06 | 2 | 107 | 2 | 8117269 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9566757 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20156433 | ||
| Pubmed | Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16. | 9.38e-06 | 2 | 107 | 2 | 2110659 | |
| Pubmed | The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. | 9.38e-06 | 2 | 107 | 2 | 21426348 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8093002 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12469224 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27876828 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 31145702 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10617600 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16133548 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25354644 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8033246 | ||
| Pubmed | Two subunits of the canine signal peptidase complex are homologous to yeast SEC11 protein. | 9.38e-06 | 2 | 107 | 2 | 2188978 | |
| Pubmed | PINK1 cleavage at position A103 by the mitochondrial protease PARL. | 9.38e-06 | 2 | 107 | 2 | 21138942 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 7695643 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16751418 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 2.81e-05 | 3 | 107 | 2 | 26067475 | |
| Pubmed | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. | 2.81e-05 | 3 | 107 | 2 | 21784188 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 32936696 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18259693 | ||
| Pubmed | Role of PARL-PINK1-Parkin pathway in adipocyte differentiation. | 2.81e-05 | 3 | 107 | 2 | 28641777 | |
| Pubmed | Junctional Rab13-binding protein (JRAB) regulates cell spreading via filamins. | 2.81e-05 | 3 | 107 | 2 | 23890175 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23995782 | ||
| Pubmed | Ontogeny of CLCN3 chloride channel gene expression in human pulmonary epithelium. | 2.81e-05 | 3 | 107 | 2 | 11306429 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26101826 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 7961757 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 2.81e-05 | 3 | 107 | 2 | 24039991 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 26455829 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16951376 | ||
| Pubmed | 4.79e-05 | 23 | 107 | 3 | 30779601 | ||
| Pubmed | 5.30e-05 | 312 | 107 | 7 | 37120454 | ||
| Pubmed | 5.47e-05 | 24 | 107 | 3 | 21080425 | ||
| Interaction | SULT1C2 interactions | 2.17e-06 | 19 | 101 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 5.85e-06 | 24 | 101 | 4 | int:SULT1A3 | |
| Interaction | SEC11B interactions | 2.49e-05 | 2 | 101 | 2 | int:SEC11B | |
| Cytoband | 14q24 | 2.92e-04 | 11 | 107 | 2 | 14q24 | |
| GeneFamily | Sulfotransferases, cytosolic | 3.44e-07 | 14 | 80 | 4 | 762 | |
| GeneFamily | Solute carriers | SLC39A11 FLVCR2 SLC18B1 SLC35D1 SLC22A8 SLC5A6 SLC39A6 SLC13A5 SLC47A1 SLC16A10 | 9.33e-06 | 395 | 80 | 10 | 752 |
| GeneFamily | Actinins | 1.15e-04 | 4 | 80 | 2 | 1112 | |
| GeneFamily | SMAD family | 5.32e-04 | 8 | 80 | 2 | 750 | |
| GeneFamily | Chloride voltage-gated channels | 8.50e-04 | 10 | 80 | 2 | 302 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.04e-03 | 11 | 80 | 2 | 559 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.62e-06 | 24 | 107 | 4 | MM1317 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.42e-05 | 75 | 107 | 5 | MM1084 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 1.80e-05 | 199 | 107 | 7 | M4571 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 1.86e-05 | 200 | 107 | 7 | M3891 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 183 | 107 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.06e-06 | 192 | 107 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 7.71e-06 | 195 | 107 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| Drug | dopamine-4-O-sulfate | 1.37e-08 | 7 | 103 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.37e-08 | 7 | 103 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.37e-08 | 7 | 103 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.37e-08 | 7 | 103 | 4 | CID011953812 | |
| Drug | mefenamic acid | 1.53e-08 | 37 | 103 | 6 | CID000004044 | |
| Drug | 2-iodophenol | 2.73e-08 | 8 | 103 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 2.73e-08 | 8 | 103 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.73e-08 | 8 | 103 | 4 | CID003037707 | |
| Drug | minoxidil sulphate | 8.49e-08 | 25 | 103 | 5 | CID000004202 | |
| Drug | A2'p5'A2'p5'A | 2.66e-07 | 31 | 103 | 5 | CID000122642 | |
| Drug | EM-139 | 2.74e-07 | 13 | 103 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 3.82e-07 | 14 | 103 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.82e-07 | 14 | 103 | 4 | CID000005888 | |
| Drug | arylsulfate | 5.19e-07 | 15 | 103 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 5.19e-07 | 15 | 103 | 4 | CID000002895 | |
| Drug | A-44 | 6.89e-07 | 16 | 103 | 4 | CID000120353 | |
| Drug | benzilic acid | 8.98e-07 | 17 | 103 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 1.45e-06 | 19 | 103 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.45e-06 | 19 | 103 | 4 | CID000442688 | |
| Drug | PLP-Glu | 1.81e-06 | 20 | 103 | 4 | CID000444293 | |
| Drug | NDPS | 1.82e-06 | 45 | 103 | 5 | CID000090363 | |
| Drug | N-hydroxy-2-aminofluorene | 2.23e-06 | 21 | 103 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.71e-06 | 22 | 103 | 4 | CID000062244 | |
| Drug | AABSSN | 2.71e-06 | 22 | 103 | 4 | CID005464134 | |
| Drug | Phosphoadenosine Phosphosulfate | 3.11e-06 | 7 | 103 | 3 | ctd:D010724 | |
| Drug | taselin | 3.27e-06 | 23 | 103 | 4 | CID000023846 | |
| Drug | AalphaC | 3.91e-06 | 24 | 103 | 4 | CID000062805 | |
| Drug | minoxidil | 4.56e-06 | 54 | 103 | 5 | CID000004201 | |
| Drug | AzMC | 4.64e-06 | 25 | 103 | 4 | CID000064986 | |
| Drug | 2-pentanone | 4.64e-06 | 25 | 103 | 4 | CID000007895 | |
| Drug | N-hydroxy-4-aminobiphenyl | 4.95e-06 | 8 | 103 | 3 | ctd:C014593 | |
| Drug | MeIQx | 4.99e-06 | 55 | 103 | 5 | CID000062275 | |
| Drug | alpha-methyldopamine | 5.47e-06 | 26 | 103 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 5.47e-06 | 26 | 103 | 4 | CID000115245 | |
| Drug | 1m2q | 5.47e-06 | 26 | 103 | 4 | CID005326637 | |
| Drug | 4-hydroxyestrone | 7.09e-06 | 59 | 103 | 5 | CID000018418 | |
| Drug | Glu-P-2 | 8.60e-06 | 29 | 103 | 4 | CID000049970 | |
| Drug | 3,3'-T2 | 9.89e-06 | 30 | 103 | 4 | CID000065559 | |
| Drug | acetaminophen sulfate | 1.13e-05 | 31 | 103 | 4 | CID000083939 | |
| Drug | barium hydroxide | 1.13e-05 | 31 | 103 | 4 | CID000028387 | |
| Drug | epicatechin-3-gallate | 1.14e-05 | 65 | 103 | 5 | CID000065056 | |
| Drug | DCNP | 1.46e-05 | 33 | 103 | 4 | CID000012066 | |
| Drug | Pyrethroids | 1.77e-05 | 71 | 103 | 5 | CID000005053 | |
| Drug | pentachlorophenol | 1.78e-05 | 120 | 103 | 6 | CID000000992 | |
| Drug | phenylglyoxal | 1.87e-05 | 121 | 103 | 6 | CID000014090 | |
| Drug | adenylylsulfate | 1.89e-05 | 72 | 103 | 5 | CID000000228 | |
| Drug | 5-hydroxymethylfurfural | 2.03e-05 | 2 | 103 | 2 | ctd:C008046 | |
| Drug | Hydroxytryptophol | 2.03e-05 | 2 | 103 | 2 | ctd:D006917 | |
| Drug | 6-hydroxymelatonin | 2.03e-05 | 2 | 103 | 2 | ctd:C012365 | |
| Drug | phenylhydroxylamine | 2.59e-05 | 38 | 103 | 4 | CID000007518 | |
| Drug | d-equilenin | 3.52e-05 | 41 | 103 | 4 | CID000010597 | |
| Drug | L-alpha-methyldopa | 3.87e-05 | 42 | 103 | 4 | CID000004138 | |
| Drug | Woodward's reagent K | 4.26e-05 | 43 | 103 | 4 | CID000077804 | |
| Drug | NSC674039 | 4.67e-05 | 44 | 103 | 4 | CID000001249 | |
| Drug | 1IIg | 5.10e-05 | 45 | 103 | 4 | CID000001682 | |
| Drug | 5-hydroxy-3-methylindole | 6.06e-05 | 3 | 103 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 6.06e-05 | 3 | 103 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 6.06e-05 | 3 | 103 | 2 | ctd:D008914 | |
| Drug | 8-azaadenine | 6.06e-05 | 3 | 103 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 6.06e-05 | 3 | 103 | 2 | ctd:C030629 | |
| Drug | 4-octylphenol | 6.07e-05 | 47 | 103 | 4 | CID000015730 | |
| Drug | salicylamide | 6.60e-05 | 48 | 103 | 4 | CID000005147 | |
| Drug | sulfamethazine | 6.60e-05 | 48 | 103 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 6.60e-05 | 48 | 103 | 4 | CID000005896 | |
| Drug | 2-Naphthylamine | 6.85e-05 | 94 | 103 | 5 | ctd:D015081 | |
| Drug | 1-naphthol | 8.36e-05 | 98 | 103 | 5 | CID000007005 | |
| Drug | adenosine 3'-5'-diphosphate | 8.36e-05 | 98 | 103 | 5 | CID000000073 | |
| Drug | 9-hydroxybenzo(a)pyrene | 9.75e-05 | 53 | 103 | 4 | CID000028598 | |
| Drug | estrone sulfate | 9.90e-05 | 163 | 103 | 6 | CID000000699 | |
| Drug | androstenediol | 1.05e-04 | 54 | 103 | 4 | CID000010634 | |
| Drug | Dopamine | 1.11e-04 | 240 | 103 | 7 | ctd:D004298 | |
| Drug | A21250 | 1.16e-04 | 105 | 103 | 5 | CID000000990 | |
| Drug | Chebi:32701 | 1.21e-04 | 4 | 103 | 2 | CID005460855 | |
| Drug | Phentolamine | 1.30e-04 | 22 | 103 | 3 | ctd:D010646 | |
| Drug | NSC36919 | 1.39e-04 | 58 | 103 | 4 | CID000235496 | |
| Drug | acetaminophen glucuronide | 1.48e-04 | 59 | 103 | 4 | CID000083944 | |
| Drug | phenolate | 1.58e-04 | 254 | 103 | 7 | CID000000996 | |
| Drug | 3-OHBaP | 1.92e-04 | 63 | 103 | 4 | CID000025890 | |
| Drug | harmol | 2.01e-04 | 5 | 103 | 2 | ctd:C001326 | |
| Drug | pinocembrin | 2.01e-04 | 5 | 103 | 2 | ctd:C016063 | |
| Drug | TKPP | 2.01e-04 | 5 | 103 | 2 | CID000023740 | |
| Drug | 4-nonylphenol | 2.04e-04 | 64 | 103 | 4 | CID000001752 | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6605_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 7293_UP | |
| Drug | 2-Sulfotrehalose | 3.00e-04 | 6 | 103 | 2 | CID000124677 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 3.00e-04 | 6 | 103 | 2 | CID000017102 | |
| Drug | 2'-phosphoadenosine 5'-phosphate | 3.38e-04 | 73 | 103 | 4 | CID000002027 | |
| Drug | 7-hydroxycoumarin | 3.75e-04 | 75 | 103 | 4 | CID005281426 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.11e-04 | 5 | 99 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | neuronal ceroid lipofuscinosis 3 (implicated_via_orthology) | 1.11e-04 | 5 | 99 | 2 | DOID:0110731 (implicated_via_orthology) | |
| Disease | response to atorvastatin, Myalgia | 3.08e-04 | 8 | 99 | 2 | EFO_0010124, HP_0003326 | |
| Disease | X-12707 measurement | 7.20e-04 | 12 | 99 | 2 | EFO_0800720 | |
| Disease | Parkinson disease | 7.59e-04 | 321 | 99 | 6 | MONDO_0005180 | |
| Disease | ascorbic acid 3-sulfate measurement | 9.88e-04 | 14 | 99 | 2 | EFO_0800173 | |
| Disease | Osteopenia | 1.14e-03 | 15 | 99 | 2 | C0029453 | |
| Disease | Liver Cirrhosis, Experimental | 1.19e-03 | 774 | 99 | 9 | C0023893 | |
| Disease | visceral adipose tissue measurement | 1.20e-03 | 481 | 99 | 7 | EFO_0004765 | |
| Disease | Autosome Abnormalities | 1.30e-03 | 16 | 99 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 1.30e-03 | 16 | 99 | 2 | C0008625 | |
| Disease | breast carcinoma (is_marker_for) | 1.44e-03 | 66 | 99 | 3 | DOID:3459 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAASGSGMAQKTWEL | 1 | Q92905 | |
| TVVGMGSWCFHMTLK | 71 | Q9NUN7 | |
| VTHMVKAGSGVWMAF | 1016 | Q9HCE6 | |
| VDGNVKMTLGMIWTI | 116 | P12814 | |
| LVASLWMKLGNTGAM | 911 | Q2NKJ3 | |
| FLMKYVWSSSGLIMV | 346 | Q9UBJ2 | |
| HVMWATSKDFGMSGL | 316 | Q96QU6 | |
| VGLTPMFGWNMKLTS | 141 | P0DMS8 | |
| SSPSMFIGQWVMDKK | 1146 | Q96Q42 | |
| TVWDLMVGAKPKTTM | 71 | Q6ZS02 | |
| TWMESFKEGIGMLVC | 826 | Q6TFL3 | |
| STDGLVMAWSMVGKY | 591 | Q5XX13 | |
| DGNAKMTLGMIWTII | 136 | O43707 | |
| ATKIWMGMVKIFSGR | 146 | P50416 | |
| SGETAFKAMMESFGW | 251 | Q8TB40 | |
| FGGQIMAWMETVATI | 201 | Q8WYK0 | |
| MGATTMDQKSLWAGV | 1 | Q15782 | |
| STDGLVMAWSMVGKY | 591 | O95170 | |
| VSKTTGMEFSMWHGS | 3336 | Q8WXI7 | |
| FMKLVIFSWISGIMV | 141 | P58181 | |
| MATSWGTVFFMLVVS | 1 | O75356 | |
| MKAWGTVVVTLATLM | 1 | Q96QH8 | |
| MRGSWVTIGVTFAAM | 156 | Q9H3K2 | |
| VTKLMDGAFWGLSNM | 251 | Q6UXM1 | |
| LTYGMMGILVKSWAQ | 941 | Q6ZRQ5 | |
| LMLWVSGSSGDIVMT | 11 | P01615 | |
| WAIISMTTVGYGDMV | 411 | Q8TDN1 | |
| GGFWAAAVTVMLVML | 11 | P05538 | |
| LAIKMMWNISAGSSS | 216 | Q9BXM7 | |
| VLMITGSWMIGSINS | 141 | Q8NG80 | |
| ASSIMPKMLGIFWFN | 76 | Q9UKL2 | |
| WSMGVITYMLLSGLS | 466 | Q9H1R3 | |
| KMMVVDGDSGSIVWS | 456 | A2RU67 | |
| MMIGLPGAGKTTWVT | 501 | Q00839 | |
| MTAKTFFIIHGWTMS | 81 | Q9Y5X9 | |
| MMKTWTLQKGFPLVT | 606 | Q9UIQ6 | |
| MGLAWTAMGGSTLFV | 766 | P36776 | |
| IMSATPTMGNTDFWK | 941 | Q9UKK3 | |
| MVVQGKRMSKETWGY | 2201 | Q7Z442 | |
| MWLAKSVPVMGVSVA | 366 | O43422 | |
| MSSMWSEYTIGGVKI | 1 | Q9BX63 | |
| WSVAGRVEMTVSKFM | 116 | Q9H974 | |
| IFMSLLVGITSGMWI | 481 | Q9ULV1 | |
| PIMVTLMVAKWTGDF | 556 | P51797 | |
| MFKFETTMTSWGLVV | 356 | P27352 | |
| WAVVTMTTVGYGDMA | 351 | Q96RP8 | |
| WKDMFAFMGSLDTKG | 261 | Q9NWV8 | |
| WVSLIEKAYMKVMGG | 371 | Q9Y6W3 | |
| GAVRMWGIMGTVLLT | 81 | Q9HB03 | |
| VSGFGKAMRMPMWSS | 631 | O14638 | |
| KVHGALMFVAWMTTV | 371 | Q6ZNA5 | |
| VWSIGVNMYAMLTGT | 246 | P57058 | |
| KGMLLGSISWVLITM | 11 | P0DN25 | |
| SGFGMEMGWLTTELK | 376 | Q9NZP8 | |
| KAVMKSMGWVTTQSP | 511 | P32189 | |
| LWVVFITAGTMGFFM | 401 | Q9UPI3 | |
| TKMSFAGTVAWMAPE | 266 | Q12852 | |
| LFWGGAMEKTGFRLM | 201 | P32019 | |
| LMLWVSGSSGDIVMT | 11 | A0A075B6P5 | |
| MGVSNLWTRVGSMVS | 446 | Q8TCC7 | |
| LGFMGVTALLSMWIS | 126 | Q86YT5 | |
| KLASWASILGFVVMM | 321 | Q8N1S5 | |
| GYGKEVDMWSTGVIM | 206 | Q16816 | |
| IAMDTAGMILGWKFF | 316 | Q9H300 | |
| VRSGWVSIMAEAMKS | 336 | Q96JX3 | |
| NSWGLTTRTIGVMTM | 1271 | P07814 | |
| NFAMIVSSALMIWKG | 36 | Q9BY50 | |
| MMVGAFFWGGLADKV | 201 | Q496J9 | |
| FLWFGTSESMMIGML | 626 | Q496J9 | |
| MVKSVIFLSFWQGML | 251 | Q9Y519 | |
| VSGLFSAMWSIGAFM | 376 | Q6NT16 | |
| RMTSGVTGDWKVMNI | 501 | P28331 | |
| LNFGMIVSSALMIWK | 11 | P0C7V7 | |
| LMIWKGLMVITGSES | 21 | P0C7V7 | |
| MAFWIGIGSIVTSMG | 466 | Q9Y289 | |
| GALTGLMETMWTYNL | 151 | Q8NGP6 | |
| LTGWSKGFIGMHREM | 371 | O94844 | |
| KTFSWGIKMTVFAMI | 156 | Q9NTN3 | |
| PRTAKMITMAVWGVS | 156 | P30874 | |
| HVWTKSKFMGMSVGV | 556 | Q9BXB5 | |
| MRKGMAGDWKTTFTV | 256 | P0DMN0 | |
| MRKGMAGDWKTTFTV | 256 | P0DMM9 | |
| ALMFATTLGVMGLWS | 426 | Q96FL8 | |
| MWSIGVLTYVMLTGI | 246 | Q9UEE5 | |
| GVATLAWMVIMGDGL | 591 | Q13433 | |
| MCTIRMSFVKGWGAE | 411 | O15198 | |
| MISGKGTFLDAWEAM | 131 | C9JRZ8 | |
| SMLSKWSTFGTLEVM | 256 | Q8NA66 | |
| MAAVMTSKWVGDAFG | 611 | P51790 | |
| WSETTMGMAIATGFL | 296 | Q53QW1 | |
| MVVGSCTDGMIKWVK | 61 | Q5JXA9 | |
| RFFGTKWMMFLAVGI | 131 | Q9H1C4 | |
| MCTIRMSFVKGWGAE | 411 | Q15796 | |
| MRKGMAGDWKTTFTV | 256 | P50225 | |
| MRKGMAGDWKTTFTV | 256 | P50226 | |
| SLGFMVWASGSMVFF | 231 | Q9GZP7 | |
| LSGEHMGAVWTMKFS | 506 | Q5JSH3 | |
| SALMIWKGLMVITGS | 31 | P67812 | |
| AVIWITAMMGGPSKL | 311 | Q14997 | |
| MMLEWLGLGVGSFTQ | 781 | Q9P2E3 | |
| SFGVLMWEVFTEGKM | 451 | P42681 | |
| GQFFSSMTLWGLAMK | 741 | Q6ZSB9 | |
| SFMKLAAVGTWMGDF | 151 | Q9H0C3 | |
| ETIFGEWTVMGSMII | 476 | Q96MT1 | |
| MSGTMGFNEFKELWA | 86 | P30626 | |
| GTESRFKQWTSMMEG | 1391 | Q9UPQ9 | |
| VFKTAWVGSLSMGMI | 111 | Q8TF71 | |
| MVKMKGYTSWGISLS | 241 | Q6ZMR3 | |
| VTMKIIAMSPAGFWQ | 1256 | Q8IZF0 |